Abc Biopply Ag

Biopply AG provides preclinical contract research services for drug efficacy, safety, toxicity, resistance, and biomarker development.

Biotechnology Research

Explore the company ↓Explore its lists ↓

Headquarters: Allschwil, SwitzerlandSource: RevenueBaseRetrieved October 13, 2026
Employee range: 1 to 10Source: RevenueBaseRetrieved October 13, 2026
Founded: 2018Source: RevenueBaseRetrieved October 13, 2026
Published list appearances: 1 supported appearance ↗Source: RevenueBase lists

The company at a glance

What does Abc Biopply Ag do?

Its preclinical services use 3D humanized multi-organoid technology with clinically relevant disease models, including oncology, neurology, hepatic and obesity models.

Based on the company’s public LinkedIn information, supplied through RevenueBase.

What the business offers

Services & capabilities.

Preclinical assays

Assays cover drug efficacy, safety, toxicology, IC50, dose response, relapse and resistance.

Source: LinkedIn company description · Retrieved October 13, 2026

Disease model development

The company can custom-tailor or design disease models and license them to clients for in-house implementation and scale-up.

Source: LinkedIn company description · Retrieved October 13, 2026

Explore the business in context

Company lists.

Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.

#20OF 25

Switzerland

Drug development analytics companies

Snapshot: September 27, 2026

↗

Positions describe ordering within each source list. See how lists are built ↗

Share your recognition

Embeddable award for your website

BADGE PREVIEW

Open the published source list.

Abc Biopply Ag

#20 Drug development analytics companies

Snapshot: September 27, 2026

Display size

Download SVG

Copy this code into your website

<a href="https://revenuebase.ai/companies/drug-development-analytics-companies/switzerland" target="_blank" rel="nofollow noopener">
  <img src="https://revenuebase.ai/companies/profiles/biopply/recognition-companies-drug-development-analytics-companies-switzerland-20260928-5ddf8a92d51281abb27a778693ea240cfdb1c9c4bc894e741695b79ac8b3420a.svg" alt="Abc Biopply Ag listed #20 on Drug development analytics companies, September 27, 2026" width="220" height="319" style="max-width:100%;height:auto;" />
</a>

View live list ↗

Sources & data notes.

RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 27, 2026. How the company lists are built.

Help keep this profile accurate

Something changed?

Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.

Request an update ↗

Find your next account

One company is just the start.

Explore more companies by name, headquarters and business focus.

Explore company profiles →